Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...

The actor expressed some regret as well as gratitude in talking about the death of his 33-year-old son from a rare form of ...

Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.

Managed Healthcare Executive asked several experts in healthcare and managed care to share the trends they think the industry ...

Joe DePinto from McKesson discussed the challenges facing cell and gene therapies, particularly around reimbursement, and ...

Insurance hurdles and the complexities of prior authorization create barriers to care, according to oncologists in a new ...

Joe DePinto, MBA, head of cell, gene and advanced therapies at McKesson , met with MHE at the annual Asembia Specialty ...

As healthcare AI evolves, there will be a greater emphasis on streamlining administrative tasks, drug production and service ...

A future where healthcare may include augmented reality, robots and drones may be more fact than fiction, says George Van Antwerp, SVP of product innovation and strategic planning at Prime ...

At this year’s Asembia conference in Las Vegas, Shawn Griffin, M.D., president and CEO of URAC, spoke about the need for ...

Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may ...